Immunolocalisation of fibrin in coronary atherosclerosis: Implications for necrotic core development

Pathology

Volumn 42, Issue 1, 2010, Pages 15-22

  Tavora, Fabio ^a   Cresswell, Nathaniel ^a   Li, Ling ^c   Ripple, Mary ^c   Burke, Allen ^a,b  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c State of Maryland   (United States)

Author keywords

Atheroma; Atherosclerosis; Coronary plaque; Fibrin II

Indexed keywords

EID: 73549125582     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313020903434348     Document Type: Article

References (23)

1. Bini A, Fenoglio JJ Jr, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 1989; 9: 109-121
2. Chalupowicz DG, Chowdhury ZA, Bach TL, Barsigian C, Martinez J. Fibrin II induces endothelial cell capillary tube formation. J Cell Biol 1995; 130: 207-215
3. Falk E, Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995; 75: 3-11B.
4. Burke AP, Virmani R, Galis Z, Haudenschild CC, Muller JE. 34th Bethesda Conference: Task force #2-What is the pathologic basis for new atherosclerosis imaging techniques? J Am Coll Cardiol 2003; 41: 1874-1886 (Erratum in: J Am Coll Cardiol 2003; 42: 1147.)
5. Stary HC. Natural history and histological classification of atherosclerotic lesions: An update. Arterioscler Thromb Vasc Biol 2000; 20: 1177-1178
6. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995; 15: 1512-1531
7. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K. Early human atherosclerosis: Accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 2007; 27: 1159-1165
8. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-1275
9. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054-2061
10. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349: 2316-2325
11. Kolodgie FD, Burke AP, Nakazawa G, Virmani R. Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol 2007; 27: 986-989
12. Burke AP, Kolodgie FD, Farb A, et al. Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression. Circulation 2001; 103: 934-940
13. Guyton JR. The role of lipoproteins in atherogenesis. Adv Exp Med Biol 1995; 369: 29-38.
14. Tabas I. Cholesterol and phospholipid metabolism in macrophages. Biochim Biophys Acta 2000; 1529: 164-174
15. Naito M, Nomura H, Esaki T, Iguchi A. Characteristics of macrophage-derived foam cells isolated from atherosclerotic lesions of rabbits. Atherosclerosis 1997; 135: 241-247
16. Tziakas DN, Kaski JC, Chalikias GK, et al. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: A new marker of clinical instability? J Am Coll Cardiol 2007; 49: 2081-2089
17. Tziakas DN, Chalikias GK, Stakos D, et al. Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease. Coron Artery Dis 2008; 19: 583-590
18. Moreno PR, Purushothaman KR, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: Implications for plaque vulnerability. Circulation 2004; 110: 2032-2038
19. Martinez M, Vaya A, Marti R, et al. Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin. Thromb Res 1996; 83: 375-388
20. Schick BP, Schick PK. Cholesterol exchange in platelets, erythrocytes and megakaryocytes. Biochim Biophys Acta 1985; 833: 281-290
21. Silvestre JS, Levy BI. Role of matrix proteolysis in angiogenesis. (French.) Journ Annu Diabetol Hotel Dieu 2002; 23-32.
22. vanHinsberghVW,Koolwijk P. Endothelial sprouting and angiogenesis: Matrix metalloproteinases in the lead. Cardiovasc Res 2008; 78: 203-212
23. Leclercq A, Houard X, Philippe M, et al. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol 2007; 82: 1420-1429